Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(3-(4-((2,6-dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5'-methoxyspiro(cyclopropane-1,3'-indolin)-2'-one MeSH Supplementary Concept Data 2026


MeSH Supplementary
2-(3-(4-((2,6-dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5'-methoxyspiro(cyclopropane-1,3'-indolin)-2'-one
Unique ID
C000592365
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000592365
Entry Term(s)
CFI-400945
Registry Numbers
0
Heading Mapped to
*Indazoles
*Indoles
Frequency
17
Note
a polo-like kinase 4 inhibitor with antineoplastic activity; structure in first source
Source
Cancer Cell. 2014 Aug 11;26(2):163-76.
Date Introduced
2014/10/12
Last Updated
2014/10/12
2-(3-(4-((2,6-dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5'-methoxyspiro(cyclopropane-1,3'-indolin)-2'-one Preferred
CFI-400945 Narrower
page delivered in 0.006s